Improved healthcare economic outcomes after liposomal bupivacaine administration in first-stage breast reconstruction

被引:3
作者
Miranda, Suzette G. [1 ]
Liu, Yusha [1 ]
Morrison, Shane D. [1 ]
Sood, Ravi F. [2 ]
Gallagher, Thomas [3 ]
Gougoutas, Alexander J.
Colohan, Shannon M.
Louie, Otway [1 ]
Mathes, David W. [4 ]
Neligan, Peter C. [1 ]
Said, Hakim K. [1 ]
机构
[1] Univ Washington, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Seattle, WA 98195 USA
[2] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA
[3] Virginia Tech, Carilion Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Roanoke, VA USA
[4] Univ Colorado, Sch Med, Dept Surg, Div Plast Surg, Denver, CO USA
关键词
DOUBLE-BLIND; HEMORRHOIDECTOMY;
D O I
10.1016/j.bjps.2016.06.031
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:1456 / 1457
页数:3
相关论文
共 5 条
[1]   Postoperative Pain and Length of Stay Lowered by Use of Exparel in Immediate, Implant-Based Breast Reconstruction [J].
Butz, Daniel R. ;
Shenaq, Deana S. ;
Rundell, Veronica L. M. ;
Kepler, Brittany ;
Liederbach, Eric ;
Thiel, Jeff ;
Pesce, Catherine ;
Murphy, Glenn S. ;
Sisco, Mark ;
Howard, Michael A. .
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2015, 3 (05)
[2]   Liposome bupivacaine for improvement in economic outcomes and opioid burden in GI surgery: IMPROVE Study pooled analysis [J].
Cohen, Stephen M. ;
Vogel, Jon D. ;
Marcet, Jorge E. ;
Candiotti, Keith A. .
JOURNAL OF PAIN RESEARCH, 2014, 7 :359-366
[3]   Bupivacaine Extended-Release Liposome Injection for Prolonged Postsurgical Analgesia in Patients Undergoing Hemorrhoidectomy: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial [J].
Gorfine, Stephen R. ;
Onel, Erol ;
Patou, Gary ;
Krivokapic, Zoran V. .
DISEASES OF THE COLON & RECTUM, 2011, 54 (12) :1552-1559
[4]  
Haas E, 2012, AM SURGEON, V78, P574
[5]   Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty [J].
Kirkness, Carmen S. ;
Asche, Carl V. ;
Ren, Jinma ;
Kim, Minchul ;
Rainville, Edward C. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (09) :E247-E254